The Valley Desk

NCT00324987 · Interventional trial

Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor

Overall registry status Terminated

Phase 3

Conditions Gastrointestinal Stromal Tumor

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov